Title : Cannabinoid-based drugs targeting CB1 and TRPV1, the sympathetic nervous system, and arthritis.

Pub. Date : 2015 Sep 6

PMID : 26343051






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Peripheral norepinephrine release from sympathetic terminals is controlled by cannabinoid receptor type 1 (CB1), which is activated by two major endocannabinoids (ECs), arachidonylethanolamine (anandamide) and 2-arachidonylglycerol. glyceryl 2-arachidonate cannabinoid receptor 1 Homo sapiens